Thu, 25 April 2019
After issuing 6 month exemptions, the U.S. pledges to fully enforce sanctions against Iranian oil exports. What does this mean for investors? In addition, huge spreads between the price of natural gas around the world has investment in liquefied natural gas (LNG) exploding. Motley Fool Contributor Jason Hall and Industry Focus host Nick Sciple discuss Chart Industries, a key provider of equipment used to cool and transform natural gas from a gaseous state to a liquid, and what opportunities it may provide to investors. Stocks Mentioned: GTLS Check out more of our content here:
|
Fri, 22 March 2019
Today we talk about a topic we've never covered before -- ETFs! Exchange-traded Funds are a great way for investors to get instant exposure to a basket of companies, and there are plenty of tech funds that have put up big returns over the past few years. We run through some solid options, and explain the difference between ETFs and mutual funds. Tickers: ETFMG, HACK, ARKW, FDN, VGT, XLK Check out more of our content here: |
Thu, 21 March 2019
Sometimes great companies are found in under-the-radar places. Graco is one of those companies. You probably haven’t heard of it (I thought it made baby strollers before doing my research), but this maker of industrial fluid and coating machinery has trounced Mr. Market over the past 25 years. Motley Fool Senior Analyst John Rotonti joins the podcast to discuss why this underfollowed company is an attractive investment today. Stocks Mentioned: GGG, SHW
Check out more of our content here: |
Fri, 15 March 2019
The original SaaS business hit a big milestone recently, we recap how the company turned CRM into a business worth over $100 billion. Then we turn our attention to a SaaS stock that's still in its early innings, Shopify. To wrap things up, we get some tips on how to talk about money with kids from a visiting team of junior analysts. Stocks: CRM, SHOP, WDAY, NOW Check out more of our content here: |
Wed, 6 March 2019
Here's why Roche's acquisition of gene therapy pioneer Spark Therapeutics and Biogen's acquisition of gene therapy upstart Nightstar Therapeutics could put Regenxbio in play. RHHBY, ONCE, BIIB, NITE, RGNX Check out more of our content here: |
Mon, 31 December 2018
Here’s what we think could happen next year, and how it could affect investors. None of us has a crystal ball that allows us to predict what the economy and stock market will do, but it’s still fun to make predictions. In this episode of Industry Focus: Financials, Fool.com contributor Matt Frankel, CFP and host Jason Moser discuss some of their boldest predictions for 2019 and what they could mean for investors. From the Fed’s interest rate moves to tech giants potentially acquiring some of our fintech favorites, there’s a lot that could happen, and we’ve got you covered. |
Thu, 8 November 2018
With Motley Fool's annual Foolapalooza gathering this week, we go to the Industry Focus Vault to bring back this episode. Michael Douglass and Fool.com Contributor Lou Whiteman discuss investment opportunities in the commercial space and defense industrie |
Wed, 7 November 2018
Why Alkermes once-promising depression drug failed to impress the FDA's advisory committee. Plus, how a $1.2 billion acquisition of Pacific Biosciences could move the needle at Illumina. Stocks: ALKS, ILMN, PACB |
Mon, 5 November 2018
It was yet another big week for earnings, and the IRS announced a big change for retirement savers. Intro: We’re now a few weeks into earnings season, and some of our favorite financials stocks just reported their latest results. Plus, wages are growing faster than they have in years and Americans can look forward to saving a little more for retirement in 2019. In this week’s episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss all of this news and more. |
Wed, 12 September 2018
In her swan song episode, Kristine shares lessons she's learned about investing while hosting the healthcare show. VEEV ISRG ILMN TDOC |